WallStSmart
CATX

Perspective Therapeutics Inc.

NYSE MKT: CATX · HEALTHCARE · MEDICAL DEVICES

$3.90
-0.89% today

Updated 2026-04-30

Market cap
$514.22M
P/E ratio
P/S ratio
581.70x
EPS (TTM)
$-1.41
Dividend yield
52W range
$2 – $6
Volume
1.6M

Perspective Therapeutics Inc. (CATX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20152015201620162017201720182018201920192020202020212021202220222023202320242025
Operating cash flow$-3.52M$-3.52M$-3.88M$-3.88M$-5.71M$-5.71M$-5.71M$-5.05M$-5.05M$-3.64M$-3.64M$-2.84M$-2.84M$-7.71M$-7.71M$-12.17M$-12.17M$-36.91M$-18.29M$-82.48M
Capital expenditures$151247.00$151247.00$491754.00$491754.00$549000.00$549000.00$337000.00$444000.00$444000.00$273000.00$273000.00$381000.00$381000.00$266000.00$266000.00$302000.00$302000.00$1.07M$54.41M$12.75M
Depreciation
Stock-based comp$205264.00$205264.00$290312.00$290312.00$372000.00$372000.00$607000.00$420000.00$420000.00$495000.00$495000.00$386000.00$386000.00$1.09M$1.09M$1.34M$1.34M$3.74M$5.39M$8.97M
Free cash flow$-3.67M$-3.67M$-4.38M$-4.38M$-6.26M$-6.26M$-6.05M$-5.49M$-5.49M$-3.91M$-3.91M$-3.22M$-3.22M$-7.98M$-7.98M$-12.47M$-12.47M$-37.98M$-72.71M$-95.23M
Investing cash flow
Financing cash flow
Dividends paid$10632.00$10632.00$10632.00$10632.00$11000.00$11000.00$11000.00$11000.00$11000.00$11000.00$11000.00$9000.00$9000.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash